Tag: FDA

SEC Charges Former CEO of Biotech Company CytoDyn with Fraud, Insider Trading
Christine Harbster December 20, 2022
Pharma and ESG – The Patient Perspective
Christine Harbster December 9, 2022
U.S. FDA Renews Annual DILIsym Software Licenses for 2022
ESG News May 5, 2022
Impossible Foods Accelerates International Expansion with Launches in Australia and New Zealand
ESG News December 30, 2021
Maine just voted to become the nation’s first ‘right to food’ state. What does that mean?
ESG News November 4, 2021